Study of the ketogenic agent AC-1202 in mild to moderate Alzheimer's disease: a randomized, double-blind, placebo-controlled, multicenter trial

by Garvin Fiona, Barr Linda J, Vogel Janet L, Henderson Samuel T, Jones Julie J, Costantini Lauren C
Published 2009-08-01